John Josey, Ph.D.

Board Chair

John Josey, Ph.D., served as the President, Chief Executive Officer, and member of the Board of Directors at Peloton Therapeutics from 2013 until its acquisition by Merck in 2019. From 2011 to 2013, he was President and Chief Scientific Officer at Peloton, and from 1998 to 2011, Vice President of Discovery Chemistry at Array Pharma.
John received a B.S. in chemistry from Colorado State University, a Ph.D. in organic chemistry from the University of Texas at Austin, and an M.B.A. from the University of Colorado. He did post-doctoral research at the California Institute of Technology. In addition to being a board member at Circle Pharma, John is also a board member at Nura Nio and Atavistik Bio.

Go to Top